We are represented particularly in the following therapeutic segments: • Anti-infectives • Central nervous system • Motor system • Hormonal system
Current pipeline With an average of 2-3 European authorisations per year, we lead the market in terms of the speed and quantity at which we bring products out of our own pipeline onto the market. We owe this performance to good collaboration between colleagues and the various disciplines; from laboratory staff to registration professionals and sales reps.
In-licensing Our range includes in-licensed products in addition to the products we ourselves develop. These are proprietary products of our pharmaceutical partners that we trade under licence on our home markets. This involves drugs such as enrofloxacin (as in injection fluid and oral solution for use in various farm animals) and the most important NSAIDs for companion animals: meloxicam and carprofen.